Geode Capital Management
HSCS icon

Geode Capital Management’s Heart Test Laboratories HSCS Stock Holding History

Geode Capital Management’s Portfolio HSCS Stock Details HSCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$71.2K Buy
28,938
+2,010
+7% +$5.86K ﹤0.01% 4226
2025
Q4 		$83.2K Buy
26,928
+14,150
+111% +$42K ﹤0.01% 4137
2025
Q3 		$44.5K Buy
12,778
+1,179
+10% +$4.29K ﹤0.01% 4317
2025
Q2 		$43.5K Buy
+11,599
New +$40.6K ﹤0.01% 4242
2024
Q2 		– Sell
-423
Closed -$4.95K – 4601
2024
Q1 		$4.95K Hold
423
– – ﹤0.01% 4586
2023
Q4 		$7.24K Hold
423
– – ﹤0.01% 4617
2023
Q3 		$18.3K Buy
+423
New +$32.8K ﹤0.01% 4637

Other funds holding HSCS

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
TA
TFB Advisors Overland Park, Kansas $191M AUM 18.47% 1-Year Est. Return
ASW
Astoria Strategic Wealth Conroe, Texas $438M AUM 16.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
TWM
Tradition Wealth Management Edina, Minnesota $1.41B AUM 19.71% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Geode Capital Management's HSCS Position: Q1 2026 in Review

Geode Capital Management increased its Heart Test Laboratories (HSCS) stake by 7.5% in Q1 2026, buying an estimated $5.86K and bringing the position to 28,938 shares worth $71.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4226.

Geode Capital Management first reported a position in HSCS in Q3 2023 and has held it in 7 quarters since. The position peaked at $83.2K in Q4 2025. 13 funds tracked by Wall St. Rank hold HSCS as of Q1 2026.

  • Geode Capital Management held 28,938 shares of Heart Test Laboratories worth $71.2K as of Q1 2026.
  • Geode Capital Management bought 2,010 Heart Test Laboratories shares in Q1 2026, an estimated $5.86K.
  • Heart Test Laboratories made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #4226 holding.
  • Geode Capital Management first reported a position in Heart Test Laboratories in Q3 2023 and has held it in 7 quarters since.
  • Geode Capital Management's Heart Test Laboratories position peaked at $83.2K in Q4 2025.
  • 13 funds tracked by Wall St. Rank held Heart Test Laboratories as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.